Modern diagnostic imaging relies heavily on intravenous contrast media (CM) to enhance visualization of pathologies. However, recent evidence suggests that the standardized or weight-adjusted CM dosing protocols commonly used in CT scans may systematically expose women to higher levels of iodine contrast than necessary. Our recent study published in European Radiology investigated sex-specific differences in iodine contrast enhancement and proposed a novel approach for more equitable and individualized CM dosing.
Key Findings
The study analyzed data from 274 patients who underwent thoracoabdominal Photon-Counting Detector CT (PCD-CT) scans in the portal-venous phase, receiving either 100 mL or 120 mL of CM. The results demonstrated that:
- Higher Iodine Contrast in Women
Women consistently showed significantly higher iodine attenuation in blood and abdominal organs compared to men when given the same volume of CM. For example, hepatic parenchymal iodine contrast was, on average, 25 HU higher in women than in men. - Influence of Physiological Parameters
Variables such as BMI, height, weight, and blood volume (BV) significantly influenced iodine contrast. However, even after adjusting for these confounders, female sex remained an independent predictor of higher contrast enhancement. - Potential of Blood Volume–Based Dosing
Correcting CM doses based on BV rather than standardized protocols eliminated sex-based differences in most measured regions, indicating that BV is a more precise parameter for individualized dosing.
Clinical Implications
These findings challenge the longstanding assumption that standardized CM protocols are universally applicable. Women may be inadvertently overdosed, increasing their risk of adverse effects, including contrast-induced nephropathy, allergic reactions, and thyroid dysfunction. Individualizing CM doses based on BV could mitigate these risks and offer additional benefits:
- Improved Safety: Reducing unnecessary iodine exposure in women could decrease the incidence of CM-related complications.
- Cost Efficiency: Personalized dosing could result in lower CM usage, reducing healthcare costs and avoiding shortages.
- Environmental Considerations: Decreasing CM waste could help address concerns about iodine contamination in water supplies.
Broader Context
This study aligns with a growing emphasis on personalized medicine, where treatments and diagnostics are tailored to individual patient characteristics. Similar trends are observed in oncology, cardiology, and pharmacology, where sex-specific differences influence drug efficacy and safety. The results also highlight the importance of leveraging advanced imaging technologies, like PCD-CT, to gain deeper insights into patient-specific physiological responses.
Next Steps
Future research should focus on validating these findings in larger, multi-center cohorts and exploring practical implementation strategies for BV-based CM dosing in routine clinical workflows. Additionally, extending this approach to other imaging modalities and patient populations (e.g., pediatrics or elderly patients) could further enhance the safety and efficacy of diagnostic imaging.
Conclusion
The findings from our study underscore the need for a paradigm shift in contrast media dosing. By moving towards individualized protocols that account for physiological differences, we can enhance patient care, improve safety, and optimize resource utilization. As healthcare continues to evolve, let’s prioritize precision and equity in every aspect of patient management.
References
Becker, J., Huber, A., Bette, S., Rubeck, A., Arndt, T. T., Müller, G., … & Decker, J. A. (2025). Are we systematically overdosing women? Revisiting standardized contrast protocols for thoracoabdominal CT scans. European Radiology, 1-10. https://link.springer.com/article/10.1007/s00330-024-11329-8
